Oracle, Cleveland Clinic, and G42 Announce Strategic Partnership to Launch AI-Based Global Healthcare Delivery Platform

Rhea-AI Summary

Oracle (ORCL), Cleveland Clinic, and G42 have announced a strategic partnership to develop an AI-powered healthcare delivery platform. The initiative will leverage Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health applications, combined with Cleveland Clinic's clinical expertise and G42's AI capabilities.

The platform aims to revolutionize healthcare delivery by enabling real-time analysis of population health data, enhancing clinical intelligence at the point of care, and improving both patient outcomes and cost efficiency. Key features include AI-driven diagnostics, personalized treatments, and improved clinical trial processes. The platform will initially launch in the U.S. and UAE, focusing on creating a scalable and cost-effective care model.

The collaboration, currently under a non-binding agreement, builds upon existing partnerships between G42 and Cleveland Clinic through Cleveland Clinic Abu Dhabi.

Positive

• Partnership combines Oracle's cloud infrastructure and AI capabilities with Cleveland Clinic's clinical expertise and G42's AI technology
• Platform aims to reduce healthcare costs while improving care quality and patient outcomes
• Will enable better clinical trial candidate identification and enrollment at point of care
• Creates opportunities for expansion in both U.S. and UAE healthcare markets

Negative

• Agreement is currently non-binding, indicating uncertainty in final implementation
• Complex integration of multiple systems and stakeholders could present execution challenges
• No specific timeline or financial details provided for platform implementation

News Market Reaction – ORCL

+0.68%

1 alert

+0.68% News Effect

On the day this news was published, ORCL gained 0.68%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Partnership will build a global AI-powered healthcare platform to deliver more effective, scalable, and affordable care

ABU DHABI, United Arab Emirates, May 16, 2025 /PRNewswire/ -- Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a groundbreaking AI-based healthcare delivery platform. This initiative aims to improve patient care and public health management by leveraging AI, nation-scale data analytics, and intelligent clinical applications to create secure, scalable, and accessible care models that positively impact people's health and longevity.

The platform will serve as the foundation for an AI-driven healthcare hub, combining Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health applications, Cleveland Clinic's world-class clinical expertise, and G42's capabilities in sovereign AI infrastructure, health data integration, and advanced clinical AI models. Designed to meet the evolving needs of global populations, starting with the U.S. and the United Arab Emirates, the platform will deliver secure, scalable, and intelligent healthcare solutions that enhance patient outcomes, enable precision medicine, and support the transition from reactive treatment to proactive wellbeing.

Powering the hospital of the future
Fully AI-enabled health systems will continually analyze population and public health data in real-time, providing practitioners with clinical intelligence at the point of care. Clinicians and public health administrators will also gain deeper insights into the well-being of patient populations at scale and the factors that may be contributing to disease progression and poor outcomes. The platform will also enable organizations to simultaneously improve care quality while driving down costs by finally giving both clinical and operational executives the data, analyses, and predictive capabilities they need to improve patient and financial outcomes.

In tandem, the collaboration will help drive a new era of life sciences innovation by removing the silos between clinical research and clinical care. Providers will be able to more easily identify clinical trial candidates and enroll them in appropriate studies at the point of care. Researchers will be able to access invaluable real-world data to detect opportunities for therapeutic intervention and closely monitor the performance and effects of existing and new therapies to limit risk, support patient safety, and get life-saving new treatments to market faster.

The platform will:

• Deliver an AI-driven healthcare infrastructure rooted in data privacy, clinical quality, and operational efficiency.
• Establish a scalable and cost-effective care model that positions the U.S. and UAE as co-leaders in supporting next-generation healthcare solutions.
• Use AI to enhance diagnostics, personalize treatments, optimize outcomes, and reduce costs at scale.
• Deliver high-quality, affordable care worldwide, addressing the rising pressures of aging populations and chronic diseases.

"Aging populations, rising costs, and the complexity of care demand a complete reinvention of how healthcare is provided," said Oracle Executive Chairman and CTO Larry Ellison. "Oracle's AI Data Platform and suite of clinical applications can help us understand disease and population health in ways that fuel scientific breakthroughs, reduce the cost of care delivery, and improve patient care. Together with Cleveland Clinic and G42, we will deliver the modern tools providers need to help people live longer, healthier lives."

"This venture represents a bold leap forward in our collective mission to transform how healthcare is delivered. As a leader in healthcare, it is a moral imperative to create solutions that benefit the health and wellness of people," said Tom Mihaljevic, MD, President and CEO, and Morton C. Mandel CEO Chair of Cleveland Clinic. "An AI-enabled model of care could positively impact global health systems - a flagship example of how data-driven, tech-powered healthcare can deliver better outcomes, lower costs, and expand access worldwide."

"At the intersection of life-saving science and transformative technology lies our greatest opportunity to redefine the future of health. This partnership between Cleveland Clinic, Oracle Health, and G42 signals the strength of the UAE–US technology corridor, and our shared resolve to build a new health intelligence fabric," said Peng Xiao, Group CEO at G42. "Together, we are advancing a model of care defined by precision, sovereignty, equity, and longevity for all."

This partnership is set to become the standard of how public-private collaboration and data-driven innovation can help dramatically improve healthcare outcomes while making care more affordable and accessible. Together, Oracle, Cleveland Clinic, and G42 will reshape the future of health for generations to come.

G42 and Cleveland Clinic have already established a strong collaboration through Cleveland Clinic Abu Dhabi and the UAE has demonstrated its commitment to enhancing healthcare delivery through its decades-long partnership with Cleveland Clinic.

The collaboration between Cleveland Clinic, G42, and Oracle is part of a non-binding agreement.

About G42
G42 is a technology holding group, a global leader in creating visionary artificial intelligence for a better tomorrow. Born in Abu Dhabi and operating worldwide, G42 champions AI as a powerful force for good across industries. From molecular biology to space exploration and everything in between, G42 realizes exponential possibilities, today. To know more visit www.g42.ai

For more information, please contact TrailRunner International: G42@trailrunnerint.com 

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.

For more information, please contact Greg Lunsford, Oracle Communications, greg.lunsford@oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic's 82,600 employees worldwide are more than 5,786 salaried physicians and researchers, and 20,700 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,728-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 280 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2024, there were 15.7 million outpatient encounters, 333,000 hospital admissions and observations, and 320,000 surgeries and procedures throughout Cleveland Clinic's health system. Patients came for treatment from every state and 112 countries. Visit us at clevelandclinic.org. Follow us at x.com/CleClinicNews. News and resources are available at newsroom.clevelandclinic.org.

Editor's Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.

View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-cleveland-clinic-and-g42-announce-strategic-partnership-to-launch-ai-based-global-healthcare-delivery-platform-302457708.html

SOURCE G42

FAQ

What is the purpose of Oracle's partnership with Cleveland Clinic and G42?

The partnership aims to develop an AI-powered healthcare delivery platform that will improve patient care, enable precision medicine, and support the transition from reactive treatment to proactive wellbeing, while making healthcare more affordable and accessible.

How will ORCL's AI healthcare platform benefit patients?

The platform will enhance patient outcomes through AI-driven diagnostics, personalized treatments, real-time health data analysis, and improved clinical intelligence at the point of care.

What technologies will Oracle use in this healthcare partnership?

The platform will utilize Oracle Cloud Infrastructure, Oracle AI Data Platform, and Oracle Health applications, combined with Cleveland Clinic's clinical expertise and G42's AI capabilities.

Where will Oracle's AI healthcare platform be initially launched?

The platform will initially launch in the United States and the United Arab Emirates, with potential for global expansion.

How will this partnership affect clinical trials and research?

The platform will improve clinical trial processes by helping identify and enroll candidates at point of care, while providing researchers access to real-world data for monitoring treatment effectiveness and safety.